Publications

1. Stewart MW. Herpetic (Non-Cytomegalovirus) Retinal Infections In Patients With The Acquired Immunodeficiency Syndrome. Curr HIV Res. 2013 Apr 01. [Epub ahead of print] 2310302
   View PubMed
2. Smith CD, Spackman T, Brommer K, Stewart MW, Vizzini M, Frye J, Rupp WC. Re-engineering the operating room using variability methodology to improve health care value. J Am Coll Surg. 2013 Apr; 216(4):559-68; discussion 568-70. 2310300
   View PubMed
3. Stewart MW. Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration. Expert Rev Clin Pharmacol. 2013 Mar; 6(2):103-13. 2309468
   View PubMed
4. Stewart MW, Bolling JP, Bendel RE. Nocardia brasiliensis endophthalmitis in a patient with an exposed Ahmed glaucoma drainage implant. Ocul Immunol Inflamm. 2013 Feb; 21(1):54-5. 2298649
   View PubMed
5. Stewart MW. Critical appraisal of ranibizumab in the treatment of diabetic macular edema. Clinical Ophthalmology. 2013; 7:1257-1267. 2331239
   
6. Stewart MW. Aflibercept as a treatment for age-related macular degeneration. US Ophthalmic Reviews. 2013; 6(1):58-63. 2318772
   
7. Stewart MW, Stewart ML. Topical azithromycin or ofloxacin for endophthalmitis. Clin Ophthalmol. 2013; 7:35-6. Epub 2012 Dec 31. 2292827
   View PubMed
8. Stewart MW. Review of aflibercept for the treatment of neovascular age-related macular degeneration. Clinical Medicine Insights: Therapeutics. 2013; 5:81-93. 2310301
   
9. Forlenza GP, Stewart MW. Diabetic retinopathy in children. Pediatr Endocrinol Rev. 2012 Dec-2013 Jan; 10(2):217-26. 2310298
   View PubMed
10. Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW. Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol. 2012 Aug; 154(2):222-6. 2247469
    View PubMed
11. Stewart MW. Corticosteroid use for diabetic macular edema: old fad or new trend? Curr Diab Rep. 2012 Aug; 12(4):364-75. 2244814
    View PubMed
12. Stewart MW. Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues. Curr Diabetes Rev. 2012 Jul 1; 8(4):237-46. 2240794
    View PubMed
13. Butendieck RR, Parikh K, Stewart M, Davidge-Pitts C, Abril A. Systemic lupus erythematosus-associated retinal vasculitis. J Rheumatol. 2012 May; 39(5):1095-6. 2242083
    View PubMed
14. Stewart MW, Rosenfeld PJ, Penha FM, Wang F, Yehoshua Z, Bueno-Lopez E, Lopez PF. Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye). Retina. 2012 Mar; 32(3):434-57. 2227681
    View PubMed
15. Gonzalez S, Rosenfeld PJ, Stewart MW, Brown J, Murphy SP. Avastin doesn't blind people, people blind people. Am J Ophthalmol. 2012 Feb; 153(2):196-203.e1. 2218798
    View PubMed
16. Stewart MW. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc. 2012 Jan; 87(1):77-88. 2215170
    View PubMed
17. Stewart MW. New anti-VEGF antibody therapies in Ophthalmology. Curr Med Literature - Ophthalmology. 2012; 22(4):105-113. 2282909
    
18. Stewart MW. Early experience using aflibercept in the treatment of wet macular degeneration. Intravitreal Interventions. 2012; 1(4):1-11. 2291537
    
19. Stewart MW. Pharmacokinetics of intravitreal anti-VEGF agents: practical clinical implications. Intervitreal Interventions. 2012; 1(1):1-4. 2259425
    
20. Stewart MW. Vascular endothelial growth factor (VEGF) biochemistry and development of inhibitory drugs. Current Drug Therapy. 2012; 7(2):80-9. 2248641
    
21. Stewart MW. Vascular endothelial growth factor inhibitor use in ophthalmology: The revolution continues. Current Drug Therapy. 2012; 7(2):77-9. 2248649
    
22. Stewart MW. Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clin Ophthalmol. 2012; 6:1175-86. Epub 2012 Jul 26. 2251131
    View PubMed
23. Vanner EA, Stewart MW, Liesegang TJ, Bendel RE, Bolling JP, Hasan SA. A retrospective cohort study of clinical outcomes for intravitreal crystalline retained lens fragments after age-related cataract surgery: a comparison of same-day versus delayed vitrectomy. Clin Ophthalmol. 2012; 6:1135-48. Epub 2012 Jul 18. 2263933
    View PubMed
24. Stewart MW. Human immunodeficiency virus and its effects on the visual system. Infectious Disease Reports. 2012; 4(1):92-100. 2276656
    
25. Stewart MW. Unilateral vision loss following contralateral eye treatment. Intravitreal Interventions. 2012; 1(2):13. 2273875
    
26. Stewart MW. Aflibercept (VEGF-TRAP): the next anti-VEGF drug. Inflamm Allergy Drug Targets. 2011 Dec; 10(6):497-508. 2199758
    View PubMed
27. Davis J, Olsen TW, Stewart M, Sternberg P Jr. How the comparison of age-related macular degeneration treatments trial results will impact clinical care. Am J Ophthalmol. 2011 Oct; 152(4):509-14. 2197524
    View PubMed
28. Vanner EA, Stewart MW. Vitrectomy timing for retained lens fragments after surgery for age-related cataracts: a systematic review and meta-analysis. Am J Ophthalmol. 2011 Sep; 152(3):345-357.e3. Epub 2011 Jun 17. 2186281
    View PubMed
29. Stewart MW, Vavra MW, Whaley NR. Fundus findings in a patient with [alpha]-methylacyl-CoA racemase deficiency. Retinal Cases and Brief Reports. 2011; 5(3):262-266. 2184520
    
30. Stewart MW. What are the half-lives of ranibizumab, aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical model. Eye Reports. 2011; 1(1):12-14. 2184522
    
31. Stewart MW. Impact of HIV on vision. Northeast Florida Medicine. 2011; 62(2):3-8. 2172105
    
32. Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010; 4:285-99. Epub 2010 Apr 26. 2001187
    View PubMed
33. Stewart MW, Rosenfeld PJ. Predicted biological activity of intravitreal VEGF Trap. Br J Ophthalmol. 2008 May; 92(5):667-8. Epub 2008 Mar 20. 1879452
    View PubMed
34. Stewart MW. Predicted biologic activity of intravitreal bevacizumab. Retina. 2007 Nov-Dec; 27(9):1196-200. 1869826
    View PubMed
35. Shetty RK, Boilling JP, Stewart MW, Heckman MG. Differences in optical coherence tomography of the macula in advanced glaucoma and after a retinal artery occlusion. Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct; 38(5):392-8. 1856335
    View PubMed
36. Stewart MW, Brazis PW, Guier CP, Thota SH, Wilson SD. Purtscher-like retinopathy in a patient with HELLP syndrome. Am J Ophthalmol. 2007 May; 143(5):886-7. 1822498
    View PubMed
37. Hasan SA, Stewart MW. Cystoid macular edema following photorefractive keratectomy complicated by presumptive infectious keratitis. J Cataract Refract Surg. 2007 Feb; 33(2):348-9. 1807236
    View PubMed
38. Stewart MW. Intravitreal bevacizumab (avastin) for the treatment of chorioretinal vascular diseases. Techniques in Ophthalmology. 2007; 5(1):40-5. 1975855
    View PubMed
39. Stewart MW, Alvarez S, Ginsburg WW, Shetty R, McLain WC, Sleater JP. Visual recovery following Mycobacterium chelonae endophthalmitis. Ocul Immunol Inflamm. 2006 Jun; 14(3):181-3. 1765664
    View PubMed
40. Hellinger WC, Hasan SA, Bacalis LP, Thornblom DM, Beckmann SC, Blackmore C, Forster TS, Tirey JF, Ross MJ, Nilson CD, Mamalis N, Crook JE, Bendel RE, Shetty R, Stewart MW, Bolling JP, Edelhauser HF. Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol. 2006 Mar; 27(3):294-8. Epub 2006 Feb 22. 1769780
    View PubMed
41. Stewart MW, Landers MB 3rd. Transscleral intraocular lens fixation with a "homemade" needle and hook. J Cataract Refract Surg. 2006 Feb; 32(2):200-2. 1757115
    View PubMed
42. Stewart MW, Liesegang TJ, Schwam BL. Chlamydia conjunctivitis and central retinal vein occlusion. Am J Ophthalmol. 2005 Jul; 140(1):161-2. 1721382
    View PubMed
43. Stewart MW. Intraoperative radiographic detection of a "lost" scleral plug. Retina. 2005 Jun; 25(4):526-7. 1718790
    View PubMed
44. Stewart MW, Brazis PW, Barrett KM, Eidelman BH, Mendez JC. Optical coherence tomography in a case of bilateral neuroretinitis. J Neuroophthalmol. 2005 Jun; 25(2):131-3. 1716349
    View PubMed
45. Stewart MW, Bolling JP, Mendez JC. Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol. 2005 Apr; 123(4):572-4. 1705160
    View PubMed
46. Stewart MW. Treatment of an avulsed retinal vessel with infrared diode laser photocoagulation. Am J Ophthalmol. 2004 Apr; 137(4):767-8. 1643047
    View PubMed
47. Brazis PW, Stewart M, Lee AG. The uveo-meningeal syndromes. Neurologist. 2004; 10(4):171-84. 1657197
    View PubMed
48. Brazis PW, Lee AG, Stewart M, Capobianco D. Clinical review: The differential diagnosis of pain in the quiet eye. Neurologist. 2002; 8(2):82-100. 1652579
    View PubMed
49. Stewart MW. Choroidal melanoma. Jacksonville Medicine. 2000; 51:393-399. 1353459
    
50. Stewart MW, Lambrou FH Jr. AIDS Retinopathy. Jacksonville Medicine. 1997; 48:347-51. 1353456
    
51. Stewart MW, Lambrou FH Jr, Watson M. Intravitreal ganciclovir injections for the treatment of cytomegalovirus retinitis. Ophthalmology. 1997; 104(Suppl):S149. 1353457
    View PubMed
52. Skowsky WR, Siddiqui T, Hodgetts D, Lambrou FH, Stewart MW, Foster MT Jr. A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and ophthalmologic effects. J Diabetes Complications. 1996; 10(2):94-9. 1353455
    View PubMed
53. Stewart MW. Update on CMV retinitis. Review of Ophthalmol. 1994 Nov:5-52. 1353453
    
54. Pogrebniak AE, Bolling JP, Stewart MW. Argon laser-induced cataract in an infant with retinopathy of prematurity. Am J Ophthalmol. 1994 Feb 15; 117(2):261-2. 1031804
    View PubMed
55. Friedman SM, Mames RN, Stewart MW. Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafovealar retinal telangiectasis. Ophthalmol Surg. 1993; 24:551-3. 1353449
    
56. Lambrou FH Jr, Stewart MW. Management of dislocated lens fragments during phacoemulsification. Ophthalmology. 1992 Aug; 99(8):1260-2; discussion 1268-9. 1353442
    View PubMed
57. Stewart MW, Lambrou FH Jr. Management of dislocated lens fragments: Pars plana vitrectomy and transscleral fixation of posterior chamber lens implants. Vitreoretinal Surg and Tech. 1992; 4(3):5-6. 1353444
    
58. Hjelmeland LM, Stewart MW, Li J, Toth CA, Burns MS, Landers MB III. An experimental model of ectropion uveae and iris neovascularization in the cat. Invest Ophthalmol Vis Sci. 1992; 33(5):1796-803. 1353441
    View PubMed
59. Landers MBL III, Stewart MW, Maberely D, Serdahl C. A new inexpensive pump for vitreoretinal surgery. Arch Ophthalmol. 1991; 109:142-3. 1353438
    View PubMed
60. Arora N, Lambrou FH Jr, Stewart MW, et al. Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron. 1991; 59:490-2. 1353439
    View PubMed
61. Lambrou FH, Stewart MW. Management of dislocated lens fragments. Ophthalmol. 1991; 98(Suppl 8):169. 1353440
    
62. Sternberg P Jr, Meredith TA, Stewart MW, Kaplan HJ. Retinal detachment in penetrating keratoplasty patients. Am J Ophthalmol. 1990; 109:148-52. 1353436
    View PubMed
63. Stewart MW, Lambrou FH Jr. Lasers and retina surgery. Jacksonville Medicine. 1990; 41:448-50. 1353437
    
64. Stewart MW, Gitter KA, Cohen G. Acute leukemia presenting as a unilateral exudative retinal detachment. Retina. 1989; 9:110-4. 1353435
    View PubMed
65. Gitter KA, Stewart MW, She SC, Paulus P, Cohen G. Practical management of diabetic retinopathy. J La State Med Soc. 1988 Oct; 140(10):26-38. 1353434
    View PubMed
66. Stewart MW, Gitter KA. Inherited retinal venous beading. Am J Ophthalmol. 1988; 106:675-81. 1353433
    View PubMed